NEW YORK (GenomeWeb) – Genome editing continues to be one of the most compelling trends in biological research as investigators maintain a steady pace of studies and papers on new CRISPR-Cas systems, innovative research tools, and various uses for the technology.

But academia is certainly not alone in its enthusiasm for CRISPR — industry is joining in as various companies are either setting out to develop new tools based on the genome editing technology or find CRISPR-based applications for tools that already exist.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.